License Agreement

Jan 28, 2022

1 min read

Scope Law advises the Swiss team of a fast-growing international specialty pharma company in in/out-licensing and IP-transfer agreement negotiations to develop, commercialize and distribute an innovative pharmaceutical products together with partners such as venture capital funds.

Life Sciences

Recent Posts

See All

New Transparency Register

On 1 October 2026, the new Federal Act on the Transparency of Legal Entities and the Identification of Beneficial Owners will enter into force. For the first time, Switzerland is introducing a central

M&A Transaction

Scope Law advised the sellers on the parallel sale of two established Swiss hospitality companies as part of a succession solution. The two transactions were structured and executed simultaneously. Co

Financing Round

Scope Law advised SquaredData AG (ETFBOOK), Zurich, on its USD 13 million funding round led by Expedition Growth Capital, with participation from existing investor BlackFin Capital Partners. ETFBOOK i

Comments